Sign in
4

Changes in Ownership

Calidi Biotherapeutics, Inc. Filed Acc 0001493152-24-024598

Options or other derivatives

  • Chief Admin. and Legal Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Campbell Wendy Pizarro Chief Admin. and Legal Officer 2024-06-17 Grant or award · Stock Options (right to buy) +40,000 40,000 D
Campbell Wendy Pizarro Chief Admin. and Legal Officer 2024-06-17 Grant or award · Stock Options (right to buy) +60,000 60,000 D
Loading xslF345X05/ownership.xml…